Department of Clinical Medicine

HemeLab

 Department of Clinical Medicine HemeLab Publications

Publications

Sort by: Date | Author | Title

Enemark, M. H., Hemmingsen, J. K., Jensen, M. L., Kridel, R. & Ludvigsen, M. (2024). Molecular Biomarkers in Prediction of High-Grade Transformation and Outcome in Patients with Follicular Lymphoma: A Comprehensive Systemic Review. International Journal of Molecular Sciences , 25(20), Article 11179. https://doi.org/10.3390/ijms252011179
Enemark, M. H., Hemmingsen, J. K., Andersen, M. D., Hybel, T. E., Bjørn, M. E., Josefsson, P. L., Pedersen, L. M., Juul, M. B., Pedersen, R. S., Thorsgaard, M., Sillesen, I. B., Plesner, T. L., Hamilton-Dutoit, S. J., Jensen, P., Madsen, C. & Ludvigsen, M. (2024). Progression of disease within 24 months (POD24) in follicular lymphoma in the rituximab era: incidence, clinicopathological risk factors, and outcome in a population-based Danish cohort. Blood Cancer Journal, 14(1), 167. Article 167. https://doi.org/10.1038/s41408-024-01150-3
Hemmingsen, J. K., Enemark, M. H., Sørensen, E. F., Lauridsen, K. L., Hamilton-Dutoit, S. J., Kridel, R., Honoré, B. & Ludvigsen, M. (2024). Proteomic Profiling Identifies Predictive Signatures for Progression Risk in Patients with Advanced-Stage Follicular Lymphoma. Cancers, 16(19), Article 3278. https://doi.org/10.3390/cancers16193278
Hershenfeld, S. A., Tobin, J. W. D., Shelton, V., Calvente, L., Lajkosz, K., Liu, T., Brodtkorb, M., d'Amore, F. A., Ludvigsen, M., Baetz, T., LeBrun, D., Johnson, N., Crump, M., Hong, M., Kuruvilla, J., Tremblay-LeMay, R., MacManus, M., Tsang, R., Hodgson, D. C. ... Kridel, R. (2024). Single gene mutations and prognosis in limited-stage follicular lymphoma treated with radiation therapy. British Journal of Haematology, 205(5), 1810-1814. https://doi.org/10.1111/bjh.19698
Neldeborg, S., Soerensen, J. F., Møller, C. T., Bill, M., Gao, Z., Bak, R. O., Holm, K., Sorensen, B., Nyegaard, M., Luo, Y., Hokland, P., Stougaard, M., Ludvigsen, M. & Holm, C. K. (2023). Dual intron-targeted CRISPR-Cas9-mediated disruption of the AML RUNX1-RUNX1T1 fusion gene effectively inhibits proliferation and decreases tumor volume in vitro and in vivo. Leukemia, 37(9), 1792-1801. https://doi.org/10.1038/s41375-023-01950-9
Enemark, M. B. H., Sørensen, E. F., Hybel, T. E., Andersen, M. D., Madsen, C., Lauridsen, K. L., Honoré, B., d'Amore, F., Plesner, T. L., Hamilton-Dutoit, S. J. & Ludvigsen, M. (2023). IDO1 Protein Is Expressed in Diagnostic Biopsies from Both Follicular and Transformed Follicular Patients. International Journal of Molecular Sciences , 24(8), Article 7314. https://doi.org/10.3390/ijms24087314
Beck Enemark, M., Wolter, K., Campbell, A. J., Andersen, M. I. D., Sørensen, E. F., Hybel, T. E., Madsen, C., Lauridsen, K. L., Plesner, T. L., Hamilton-Dutoit, S. J., Honoré, B. & Ludvigsen, M. (2023). Proteomics identifies apoptotic markers as predictors of histological transformation in patients with follicular lymphoma. Blood Advances, 7(24), 7418-7432. https://doi.org/10.1182/bloodadvances.2023011299
Ludvigsen, M., Campbell, A. J., Enemark, M. B., Hybel, T. E., Karjalainen-Lindsberg, M.-L., Beiske, K., Bjerre, M., Pedersen, L. M., Holte, H., Leppä, S., Jørgensen, J. M. & Honoré, B. (2023). Proteomics uncovers molecular features for relapse risk stratification in patients with diffuse large B-cell lymphoma. Blood Cancer Journal, 13(1), Article 161. https://doi.org/10.1038/s41408-023-00931-6
Simonsen, A. T., Meggendorfer, M., Hansen, M. H., Nederby, L., Koch, S., Hansen, M., Rosenberg, C. A., Kern, W., Nyvold, C. G., Aggerholm, A., Haferlach, T. & Ommen, H. B. (2022). Acute myeloid leukemia exhibiting clonal instability during treatment: Implications for measurable residual disease assessments. Experimental Hematology, 107, 51-59. https://doi.org/10.1016/j.exphem.2022.01.001
Hybel, T. E., Vase, M. Ø., Lauridsen, K. L., Enemark, M. B., Møller, M. B., Pedersen, C., Pedersen, G., Hamilton-Dutoit, S., Obel, N., Schade Larsen, C., d’Amore, F. & Ludvigsen, M. (2022). CD38 is a potential treatment target in lymphoma patients concurrently infected with human immunodeficiency virus. Leukemia & Lymphoma, 63(6), 1479-1483. https://doi.org/10.1080/10428194.2021.2023741
Honoré, B., Andersen, M. D., Wilken, D., Kamper, P., d'Amore, F., Hamilton-Dutoit, S. & Ludvigsen, M. (2022). Classic Hodgkin Lymphoma Refractory for ABVD Treatment Is Characterized by Pathologically Activated Signal Transduction Pathways as Revealed by Proteomic Profiling. Cancers, 14(1), Article 247. https://doi.org/10.3390/cancers14010247
Soerensen, J. F., Aggerholm, A., Rosenberg, C. A., Bill, M., Kerndrup, G. B., Ebbesen, L. H., Hansen, M. H., Roug, A. S. & Ludvigsen, M. (2022). Clonal evolution in patients developing therapy-related myeloid neoplasms following autologous stem cell transplantation. Bone Marrow Transplantation, 57(3), 460-465. https://doi.org/10.1038/s41409-022-01567-z
Hussmann, D., Starnawska, A., Kristensen, L., Daugaard, I., Thomsen, A., Kjeldsen, T., Hansen, C. S., Bybjerg-Grauholm, J., Dalsgaard Johansen, K., Ludvigsen, M., Kristensen, T., Larsen, T. S., Møller, M. B., Nyvold, C. G., Hansen, L. L. & Wojdacz, T. K. (2022). IGHV-associated methylation signatures more accurately predict clinical outcomes of chronic lymphocytic leukemia patients than IGHV mutation load. Haematologica, 107(4), 877-886. https://doi.org/10.3324/haematol.2021.278477
Rosenberg, C. A., Bill, M., Maguire, O., Petersen, M. A., Kjeldsen, E., Hokland, P. & Ludvigsen, M. (2022). Imaging flow cytometry reveals a subset of TdT negative T-ALL blasts with very low forward scatter on conventional flow cytometry. Cytometry. Part B: Clinical Cytometry, 102(2), 107-114. https://doi.org/10.1002/cyto.b.22035
Petersen, M. A., Rosenberg, C. A., Brøndum, R. F., Aggerholm, A., Kjeldsen, E., Rahbek, O., Ludvigsen, M., Hasle, H., Roug, A. S. & Bill, M. (2022). Immunophenotypically defined stem cell subsets in paediatric AML are highly heterogeneous and demonstrate differences in BCL-2 expression by cytogenetic subgroups. British Journal of Haematology, 197(4), 452-466. https://doi.org/10.1111/bjh.18094
Petersen, M. A., Rosenberg, C. A., Bill, M., Enemark, M. B., Rahbek, O., Roug, A. S., Hasle, H., Honoré, B. & Ludvigsen, M. (2022). Proteomic Profiling Identifies Specific Leukemic Stem Cell-Associated Protein Expression Patterns in Pediatric AML Patients. Cancers, 14(15), Article 3567. https://doi.org/10.3390/cancers14153567
Dietrichs, D., Grimm, D., Sahana, J., Melnik, D., Corydon, T. J., Wehland, M., Krüger, M., Vermeesen, R., Baselet, B., Baatout, S., Hybel, T. E., Kahlert, S., Schulz, H., Infanger, M. & Kopp, S. (2022). Three-Dimensional Growth of Prostate Cancer Cells Exposed to Simulated Microgravity. Frontiers in Cell and Developmental Biology, 10, Article 841017. https://doi.org/10.3389/fcell.2022.841017
Enemark, M. B., Hybel, T. E., Madsen, C., Lauridsen, K. L., Honoré, B., Plesner, T. L., Hamilton-Dutoit, S., D’amore, F. & Ludvigsen, M. (2022). Tumor-Tissue Expression of the Hyaluronic Acid Receptor RHAMM Predicts Histological Transformation in Follicular Lymphoma Patients. Cancers, 14(5), Article 1316. https://doi.org/10.3390/cancers14051316
Holst, J. M., Enemark, M. B., Plesner, T. L., Pedersen, M. B., Ludvigsen, M. & d'Amore, F. (2021). Coexisting BRAF-Mutated Langerhans Cell Histiocytosis and Primary Myelofibrosis with Shared JAK2 Mutation. Case Reports in Hematology, 2021, Article 6623706. https://doi.org/10.1155/2021/6623706
Rosenberg, C. A., Bill, M., Rodrigues, M. A., Hauerslev, M., Kerndrup, G. B., Hokland, P. & Ludvigsen, M. (2021). Exploring dyserythropoiesis in patients with myelodysplastic syndrome by imaging flow cytometry and machine-learning assisted morphometrics. Cytometry. Part B: Clinical Cytometry, 100(5), 554-567. https://doi.org/10.1002/cyto.b.21975

Displaying results 21 to 40 out of 128

Previous

1

2

3

4

5

6

7

Next

Revised 11.09.2025
-
Maja Ludvigsen